United States · FDA National Drug Code directory

DULOXETINE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62332-279_68db1bf0-65d7-4c3a-94ec-79209242a3d0
Product NDC: 62332-279
Form: CAPSULE, DELAYED RELEASE
Composition / generic term: Duloxetine
Labeler: Alembic Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260409
Source listing expiry: 20271231

Source-listed ingredients

DULOXETINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-279-30) · 62332-279-30
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-279-90) · 62332-279-90
1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-279-91) · 62332-279-91

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →